JOHNSON LORIN K 4/A
4/A · Edesa Biotech, Inc. · Filed Jan 13, 2020
Insider Transaction Report
Form 4/AAmended
JOHNSON LORIN K
Director
Transactions
- Award
Common Share Warrants (Right to Buy)
2020-01-08+6,393→ 6,393 totalExercise: $4.80From: 2020-07-08Exp: 2023-07-08→ Common Shares (6,393 underlying) - Award
Common Share Warrants (Right to Buy)
2020-01-08+4,262→ 4,262 totalExercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (4,262 underlying) - Award
Common Shares
2020-01-08$4.11/sh+8,524$35,034→ 8,524 total
Footnotes (4)
- [F1]The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share.
- [F2]Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023.
- [F3]Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020.
- [F4]Amended to reflect acquisition from the issuer.